JP Morgan Chase
ARMP icon

JP Morgan Chase’s Armata Pharmaceuticals ARMP Stock Holding History

JP Morgan Chase’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-24
Closed -$72 – 7407
2025
Q3 		$72 Hold
24
– – ﹤0.01% 7195
2025
Q2 		$46 Buy
24
+2
+9% +$3 ﹤0.01% 6902
2025
Q1 		$32 Sell
22
-3
-12% -$6 ﹤0.01% 7052
2024
Q4 		$46 Sell
25
-1
-4% -$2 ﹤0.01% 7146
2024
Q3 		$62 Sell
26
-1
-4% -$3 ﹤0.01% 7077
2024
Q2 		$74 Buy
27
+1
+4% +$3 ﹤0.01% 6949
2024
Q1 		$109 Sell
26
-79
-75% -$286 ﹤0.01% 6891
2023
Q4 		$340 Buy
+105
New +$248 ﹤0.01% 6984
2023
Q3 		– Sell
-148
Closed -$169 – 7448
2023
Q2 		$169 Buy
+148
New +$215 ﹤0.01% 6646
2020
Q4 		– Sell
-9
Closed – – 5611
2020
Q3 		$0 Hold
9
– – ﹤0.01% 5466
2020
Q2 		$0 Buy
+9
New +$31 ﹤0.01% 5354
2019
Q1 		– Sell
-64
Closed – – 5749
2018
Q4 		$0 Buy
+64
New +$312 ﹤0.01% 5674

Other funds holding ARMP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return

JP Morgan Chase's ARMP Position: Q4 2025 in Review

JP Morgan Chase sold out of Armata Pharmaceuticals (ARMP) in Q4 2025, closing a stake of 24 shares — an estimated $72 sold.

JP Morgan Chase first reported a position in ARMP in Q4 2018 and held it in 12 quarters. The position peaked at $340 in Q4 2023. 36 funds tracked by Wall St. Rank hold ARMP as of Q4 2025.

  • JP Morgan Chase reported no remaining Armata Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • JP Morgan Chase sold 24 Armata Pharmaceuticals shares in Q4 2025, an estimated $72.
  • JP Morgan Chase first reported a position in Armata Pharmaceuticals in Q4 2018 and held it in 12 quarters.
  • JP Morgan Chase's Armata Pharmaceuticals position peaked at $340 in Q4 2023.
  • 36 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q4 2025.

Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.